Page last updated: 2024-09-02

kt 5823 and n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide

kt 5823 has been researched along with n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide in 1 studies

Compound Research Comparison

Studies
(kt 5823)
Trials
(kt 5823)
Recent Studies (post-2010)
(kt 5823)
Studies
(n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide)
Trials
(n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide)
Recent Studies (post-2010) (n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide)
317059256112

Protein Interaction Comparison

ProteinTaxonomykt 5823 (IC50)n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide (IC50)
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)5.3
RAC-beta serine/threonine-protein kinaseHomo sapiens (human)7.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golombek, DA; Mathur, A; Ralph, MR1

Other Studies

1 other study(ies) available for kt 5823 and n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide

ArticleYear
cGMP-dependent protein kinase inhibitors block light-induced phase advances of circadian rhythms in vivo.
    The American journal of physiology, 1996, Volume: 270, Issue:5 Pt 2

    Topics: Alkaloids; Animals; Carbazoles; Circadian Rhythm; Cricetinae; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Indoles; Isoquinolines; Light; Male; Mesocricetus; Motor Activity

1996